Kidney function may affect how obesity drug works
NCT ID NCT07347808
First seen Jan 17, 2026 · Last updated May 21, 2026 · Updated 16 times
Summary
This study looked at how a single dose of the experimental drug VCT220 behaves in 16 people with moderate kidney problems compared to 16 people with normal kidneys. The goal was to see if kidney function changes drug levels and safety. Results will help doctors decide the right dose for patients with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Conditions
Explore the condition pages connected to this study.